Article
Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.
PloS one - 1 Jan 2020
Sadasivan Chandu, Chow Josie T Y, Sheng Bun, Chan David K H, Fan Yiting, Choi Paul C L, Wong Jeffrey K T, Tong Mabel M B, Chan Tsz-Ngai, Fung Erik, Kam Kevin K H, Chan Joseph Y S, Chi Wai-Kin, Paterson D Ian, Senaratne Manohara, Brass Neil, Oudit Gavin Y, Lee Alex P W
Abstract excerpt
Fabry Disease (FD) is a systemic disorder that can result in cardiovascular, renal, and neurovascular disease leading to reduced life expectancy. FD should be considered in the differential of all patients with unexplained left ventricular hypertrophy (LVH). We therefore performed a prospective screening study in Edmonton and Hong Kong using Dried Blood Spot (DBS) testing on patients with undiagnosed LVH....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.